Is Rspo1 a friend or foe in ESCC? Rethinking wnt signaling in tumor prognostics
Indian Journal of Pathology and Microbiology · 2026-07 · 69 (3) · 586-587
DOI: 10.4103/ijpm.ijpm_488_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pathology and Microbiology, online erschienen am 28.09.2026. Verfasst von Haewon Byeon. Beteiligte Einrichtung: Worker's Care and Digital Health Lab, Korea University of Technology and Education (KOREA TECH), Cheonan, South Korea. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Worker's Care and Digital Health Lab, Korea University of Technology and Education (KOREA TECH), Cheonan, South Korea.
Zitieren
APA
Byeon, H. (2026). Is Rspo1 a friend or foe in ESCC? Rethinking wnt signaling in tumor prognostics. Indian Journal of Pathology and Microbiology, 69(3), 586-587. https://doi.org/10.4103/ijpm.ijpm_488_25
Vancouver
Byeon H. Is Rspo1 a friend or foe in ESCC? Rethinking wnt signaling in tumor prognostics. Indian Journal of Pathology and Microbiology. 2026;69(3):586-587. doi:10.4103/ijpm.ijpm_488_25
BibTeX
@article{Byeon2026,
author = {Byeon, Haewon},
title = {Is Rspo1 a friend or foe in ESCC? Rethinking wnt signaling in tumor prognostics},
journal = {Indian Journal of Pathology and Microbiology},
year = {2026},
volume = {69},
number = {3},
pages = {586--587},
doi = {10.4103/ijpm.ijpm_488_25}
}
EUVIMED